Organization Overview
Alternative names
aflibercept (zaltrap) (1 trial)
bevacizumab (avastin) (1 trial)
cabazitaxel (jevtana kit) (2 trials)
docetaxel (taxotere) (1 trial)
durvalumab (imfinzi) (1 trial)
everolimus (zortress) (1 trial)
fluorouracil (efudex) (2 trials)
Adenocarcinoma (Phase 2)
Amyloidosis (Phase 2)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Cholangiocarcinoma (Phase 2)
Colorectal Neoplasms (Phase 2)
Digestive System Neoplasms (Phase 2)
Gallbladder Neoplasms (Phase 2)
Gastrointestinal Neoplasms (Phase 2)
Intestinal Neoplasms (Phase 2)
Kidney Neoplasms (Phase 2)
Lung Neoplasms (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Second Primary (Phase 2)
Neuroendocrine Tumors (Phase 2)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 2)
